Squarepoint Ops LLC Allakos Inc. Transaction History

Squarepoint Ops LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$1.0 - $1.45 $63,190 - $91,625	63,190 New	63,190 $63,000
Q1 2023 May 15, 2023	BUY	$4.3 - $8.27 $561,175 - $1.08 Million	130,506 New	130,506 $580,000
Q2 2022 Aug 15, 2022	SELL	$2.6 - $6.14 $361,857 - $854,540	-139,176 Reduced 53.49%	121,007 $379,000
Q1 2022 May 16, 2022	SELL	$5.08 - $9.81 $28,026 - $54,121	-5,517 Reduced 2.08%	260,183 $1.48 Million
Q4 2021 Feb 14, 2022	BUY	$8.55 - $111.89 $2.27 Million - $29.7 Million	265,700 New	265,700 $2.6 Million
Q3 2021 Nov 15, 2021	SELL	$76.53 - $110.43 $600,913 - $867,096	-7,852 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$85.37 - $114.1 $670,325 - $895,913	7,852 New	7,852 $670,000
Q4 2020 Feb 16, 2021	SELL	$79.58 - $152.45 $297,549 - $570,010	-3,739 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$66.43 - $90.99 $248,381 - $340,211	3,739 New	3,739 $305,000
Q2 2020 Aug 14, 2020	SELL	$44.04 - $80.69 $312,243 - $572,092	-7,090 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$44.49 - $93.39 $5,605 - $11,767	-126 Reduced 1.75%	7,090 $315,000
Q4 2019 Feb 14, 2020	BUY	$66.49 - $137.73 $479,791 - $993,859	7,216 New	7,216 $688,000
Q2 2019 Aug 14, 2019	SELL	$36.0 - $44.73 $489,996 - $608,820	-13,611 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$33.79 - $51.99 $459,915 - $707,635	13,611 New	13,611 $551,000

64.7M

47.1K

Ticker ALLK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,726,096
Market Cap $98.3M
Description
Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and...

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

Stay updated on Squarepoint Ops LLC with notifications on news.